TONYA COLTON: Open Payments
NPI 1467793703 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,282 in 99 payments from 15 companies in 2025. Trend: 2023 $1,132 · 2024 $1,580 · 2025 $2,282
Food & beverage: $2,282
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $449 |
| Neurocrine BioSciences, Inc. | 14 | $415 |
| E.R. Squibb & Sons, L.L.C. | 10 | $326 |
| Axsome Therapeutics, Inc. | 12 | $222 |
| Collegium Pharmaceutical, Inc. | 9 | $199 |
| Alkermes, Inc. | 8 | $169 |
| Vanda Pharmaceuticals Inc. | 6 | $157 |
| Janssen Pharmaceuticals, Inc | 6 | $135 |
| Corium, LLC | 3 | $75 |
| Neos Therapeutics, LP | 2 | $29 |
Products named: CAPLYTA, INGREZZA, COBENFY, Jornay PM, Auvelity, ARISTADA, FANAPT, Azstarys.
Industry payments across VA — which companies pay providers there.
